Glatt, S., Baeten, D., Baker, T., Griffiths, M., Ionescu, L., Lawson, A. D. G., Maroof, A., Oliver, R., Popa, S., Strimenopoulou, F., Vajjah, P., Watling, M. I. L., Yeremenko, N., Miossec, P., & Shaw, S. (2018). dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation. Annals of the rheumatic diseases, 77(4), 523–532. http://access.bl.uk/ark:/81055/vdc_100137787195.0x00005e